{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:16:48Z","timestamp":1792603008301,"version":"4.5.0"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK049362"],"award-info":[{"award-number":["R01-DK049362"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["NCI CCSG P30 CA060553"],"award-info":[{"award-number":["NCI CCSG P30 CA060553"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0155534","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T17:41:17Z","timestamp":1463506877000},"page":"e0155534","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Anti-TGF-\u03b2 Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria"],"prefix":"10.1371","volume":"11","author":[{"given":"Xiaoyan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. William","family":"Schnaper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Matsusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Pastan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Ledbetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.semnephrol.2007.02.009","article-title":"TGF-\u03b2 in renal injury and disease","volume":"27","author":"EP Bottinger","year":"2007","journal-title":"Semin Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI116874","article-title":"Glomerulosclerosis induced by in vivo transfection of transforming growth factor-\u03b2 or platelet-derived growth factor gene into the rat kidney","volume":"92","author":"Y Isaka","year":"1993","journal-title":"J Clin Invest"},{"key":"ref3","first-page":"991","article-title":"Transgenic mice with increased plasma levels of TGF-\u03b21 develop progressive renal disease","volume":"74","author":"JB Kopp","year":"1996","journal-title":"Lab Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1681\/ASN.V102271","article-title":"Renal expression of fibrotic matrix proteins and of transforming growth factor-\u03b2 isoforms in TGF-\u03b2 transgenic mice","volume":"10","author":"MM Mozes","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.emboj.7600069","article-title":"Integration of TGF-\u03b2 \/Smad and Jagged1\/Notch signalling in epithelial-to-mesenchymal transition","volume":"23","author":"J Zavadil","year":"2004","journal-title":"EMBO"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4161\/19336918.2014.972788","article-title":"Extracellular matrix as a contextual determinant of transforming growth factor-\u03b2 signaling in epithelial-mesenchymal transition and in cancer","volume":"8","author":"MA Cichon","year":"2014","journal-title":"Cell Adh Migr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/ndt\/17.12.2145","article-title":"Transforming growth factor-\u03b2 1 in the kidney and urine of patients with glomerular disease and proteinuria","volume":"17","author":"DS Goumenos","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s004670050289","article-title":"Urinary transforming growth factor-\u03b2 in patients with glomerular diseases","volume":"11","author":"K Murakami","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000109396","article-title":"Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood","volume":"28","author":"RP Woroniecki","year":"2008","journal-title":"Am J Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1046\/j.1523-1755.2003.00288.x","article-title":"Activation of the TGF-\u03b2\/Smad signaling pathway in focal segmental glomerulosclerosis","volume":"64","author":"JH Kim","year":"2003","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00467-004-1619-5","article-title":"Transforming growth factor-\u03b21 in nephrotic syndrome treated with cyclosporine and ACE inhibitors","volume":"19","author":"AM Wasilewska","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ki.2009.66","article-title":"Circulating transforming growth factor-\u03b21 levels and the risk for kidney disease in African Americans","volume":"76","author":"M Suthanthiran","year":"2009","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/ki.2012.383","article-title":"Circulating bone morphogenetic protein-7 and transforming growth factor-\u03b21 are better predictors of renal end points in patients with type 2 diabetes mellitus","volume":"83","author":"MG Wong","year":"2013","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/346281a0","article-title":"Negative regulation of transforming growth factor-\u03b2 by the proteoglycan decorin","volume":"346","author":"Y Yamaguchi","year":"1990","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/360361a0","article-title":"Natural inhibitor of transforming growth factor-\u03b2 protects against scarring in experimental kidney disease","volume":"360","author":"WA Border","year":"1992","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2009.05.010","article-title":"Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts","volume":"385","author":"S Schievenbusch","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1681\/ASN.2006080901","article-title":"Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice","volume":"18","author":"SM Ka","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/diab.45.4.522","article-title":"Neutralization of TGF-\u03b2 by anti-TGF-\u03b2 antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice","volume":"45","author":"K Sharma","year":"1996","journal-title":"Diabetes"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1073\/pnas.120055097","article-title":"Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-\u03b2 antibody in db\/db diabetic mice","volume":"97","author":"FN Ziyadeh","year":"2000","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ki.2012.139","article-title":"Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis","volume":"82","author":"G Finer","year":"2012","journal-title":"Kidney Int"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1523-1755.1999.00275.x","article-title":"Gene therapy by transforming growth factor-\u03b2 receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis","volume":"55","author":"Y Isaka","year":"1999","journal-title":"Kidney Int"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1046\/j.1523-1755.2001.00990.x","article-title":"Effects of anti-TGF-\u03b2 type II receptor antibody on experimental glomerulonephritis","volume":"60","author":"H Kasuga","year":"2001","journal-title":"Kidney Int"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.4049\/jimmunol.142.5.1536","article-title":"Monoclonal antibodies recognizing transforming growth factor \u03b2. Bioactivity neutralization and transforming growth factor beta 2 affinity purification","volume":"142","author":"JR Dasch","year":"1989","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/01.ASN.0000074238.61967.B7","article-title":"Add-on anti-TGF-\u03b2 antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat","volume":"14","author":"A Benigni","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1159\/000094967","article-title":"Beneficial effect of TGF-\u03b2 antagonism in treating diabetic nephropathy depends on when treatment is started","volume":"104","author":"A Benigni","year":"2006","journal-title":"Nephron Exp Nephrol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1523-1755.2004.00901.x","article-title":"Combining TGF- \u03b2 inhibition and angiotensin II blockade results in enhanced antifibrotic effect","volume":"66","author":"L Yu","year":"2004","journal-title":"Kidney Int"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/01.hjh.0000182521.44440.c5","article-title":"Neutralization of transforming growth factor-\u03b2 attenuates hypertension and prevents renal injury in uremic rats","volume":"23","author":"P Lavoie","year":"2005","journal-title":"J Hypertens"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1152\/ajpregu.00263.2011","article-title":"Renoprotective effects of anti-TGF-\u03b2 antibody and antihypertensive therapies in Dahl S rats","volume":"303","author":"SR Murphy","year":"2012","journal-title":"Am J Physiol, Regul Integr Comp Physiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1046\/j.1523-1755.2000.00414.x","article-title":"Antibody to transforming growth factor-\u03b2 ameliorates tubular apoptosis in unilateral ureteral obstruction","volume":"58","author":"A Miyajima","year":"2000","journal-title":"Kidney Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.ASN.0000042168.43665.9B","article-title":"Therapeutic role of TGF-\u03b2 -neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation","volume":"14","author":"H Ling","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1681\/ASN.2004080720","article-title":"Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury","volume":"16","author":"T Matsusaka","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref32","first-page":"968","article-title":"Accumulation of a recombinant immunotoxin in a tumor in vivo: fewer than 1000 molecules per cell are sufficient for complete responses","volume":"58","author":"RJ Kreitman","year":"1998","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1172\/JCI119066","article-title":"D-glucose-induced dysmorphogenesis of embryonic kidney","volume":"98","author":"YS Kanwar","year":"1996","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-60327-345-9_3","article-title":"Laser-capture microdissection and pressure catapulting for the analysis of gene expression in the renal glomerulus","volume":"611","author":"AJ Edgley","year":"2010","journal-title":"Methods Mol Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"F1323","DOI":"10.1152\/ajprenal.00155.2013","article-title":"Hypoxia-inducible factor-2\u03b1 and TGF-\u03b2 signaling interact to promote normoxic glomerular fibrogenesis","volume":"305","author":"C Hanna","year":"2013","journal-title":"Am J Phsiol, Renal Physiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1681\/ASN.2007111205","article-title":"Adriamycin alters glomerular endothelium to induce proteinuria","volume":"20","author":"M Jeansson","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e55027","DOI":"10.1371\/journal.pone.0055027","article-title":"Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy","volume":"8","author":"YB Sun","year":"2013","journal-title":"PloS one"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013121336","article-title":"Renal F4\/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy","volume":"26","author":"Q Cao","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"ref39","first-page":"1414","article-title":"Schrier's Diesase of the Kidney","author":"HW Schnaper","year":"2013"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1681\/ASN.2005010055","article-title":"Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene","volume":"16","author":"BL Wharram","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1681\/ASN.2013020173","article-title":"Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases","volume":"24","author":"L Wickman","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"F553","DOI":"10.1152\/ajprenal.00056.2013","article-title":"Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury","volume":"305","author":"H Zhou","year":"2013","journal-title":"Am J Physiol, Renal Physiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/kisup.2014.2","article-title":"Overview of the cellular and molecular basis of kidney fibrosis","volume":"4","author":"AA Eddy","year":"2014","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2014a common pathway to organ injury and failure","volume":"372","author":"DC Rockey","year":"2015","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"F1657","DOI":"10.1152\/ajprenal.00274.2007","article-title":"Interference with TGF-\u03b2 signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria","volume":"293","author":"A Wang","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/labinvest.3780196","article-title":"TGF-\u03b21-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man","volume":"80","author":"S Krag","year":"2000","journal-title":"Lab Invest"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2011.255","article-title":"Canonical Wnt\/\u03b2-catenin signaling mediates transforming growth factor-\u03b21-driven podocyte injury and proteinuria","volume":"80","author":"D Wang","year":"2011","journal-title":"Kidney Int"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"37004","DOI":"10.1074\/jbc.M403534200","article-title":"A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-\u03b2-induced apoptosis","volume":"279","author":"M Schiffer","year":"2004","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1523-1755.2005.00574.x","article-title":"The cyclin-dependent kinase inhibitor p21 is required for TGF-\u03b21-induced podocyte apoptosis","volume":"68","author":"T Wada","year":"2005","journal-title":"Kidney Int"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"F155","DOI":"10.1152\/ajprenal.00438.2013","article-title":"Upregulation of mitochondrial Nox4 mediates TGF-\u03b2-induced apoptosis in cultured mouse podocytes","volume":"306","author":"R Das","year":"2014","journal-title":"Am J Physiol. Renal Physiol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1523-1755.1999.00636.x","article-title":"Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis","volume":"56","author":"YM Chen","year":"1999","journal-title":"Kidney Int"},{"key":"ref52","first-page":"167","article-title":"Effects of 5\/6 nephrectomy on renal function and blood pressure in mice","volume":"4","author":"AL Gava","year":"2012","journal-title":"Int Physiol Pathophysiol Pharmacol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/0886022X.2013.867797","article-title":"Pathological changes, TGF-\u03b21 expression, and the effects of hepatocyte growth factor in 5\/6 nephrectomized rats","volume":"36","author":"HY Wang","year":"2014","journal-title":"Ren Fail"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/aje\/kwu067","article-title":"Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health study","volume":"179","author":"I Agarwal","year":"2014","journal-title":"Am J Epidemiol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-physiol-020911-153238","article-title":"Cell biology and pathology of podocytes","volume":"74","author":"A Greka","year":"2012","journal-title":"Annu Rev Physiol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1681\/ASN.2010090963","article-title":"Podocyte injury damages other podocytes","volume":"22","author":"T Matsusaka","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ki.2009.424","article-title":"Proteinuria: an enzymatic disease of the podocyte?","volume":"77","author":"P Mundel","year":"2010","journal-title":"Kidney Int"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2011.151","article-title":"The podocyte cytoskeleton\u2014key to a functioning glomerulus in health and disease","volume":"8","author":"GI Welsh","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ki.2013.175","article-title":"Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury","volume":"84","author":"SM Blattner","year":"2013","journal-title":"Kidney Int"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1128\/MCB.00730-13","article-title":"Rac1 activation in podocytes induces rapid foot process effacement and proteinuria","volume":"33","author":"H Yu","year":"2013","journal-title":"Mol Cell Biol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fendo.2014.00207","article-title":"Structural analysis of how podocytes detach from the glomerular basement membrane under hypertrophic stress","volume":"5","author":"W Kriz","year":"2014","journal-title":"Front Endocrinol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1681\/ASN.2014030278","article-title":"A Potential Role for Mechanical Forces in the Detachment of Podocytes and the Progression of CKD","volume":"26","author":"W Kriz","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.semnephrol.2013.11.009","article-title":"Regulation of autophagy by TGF-\u03b2: emerging role in kidney fibrosis","volume":"34","author":"Y Ding","year":"2014","journal-title":"Semin Nephrol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0155534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T07:13:22Z","timestamp":1692342802000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0155534"}},"subtitle":[],"editor":[{"given":"Maria Pia","family":"Rastaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":63,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0155534","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]}}}